Cargando…

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

Detalles Bibliográficos
Autores principales:	Halpin, David M G, Faner, Rosa, Sibila, Oriol, Badia, Joan Ramon, Agusti, Alvar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270536/ https://www.ncbi.nlm.nih.gov/pubmed/32251625 http://dx.doi.org/10.1016/S2213-2600(20)30167-3

Ejemplares similares

Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2021)

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19
por: Cruz, Tamara, et al.
Publicado: (2023)

SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae
por: Cruz, Tamara, et al.
Publicado: (2022)

Role of respiratory intermediate care units during the SARS-CoV-2 pandemic
por: Matute-Villacís, Mónica, et al.
Publicado: (2021)

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge
por: Sibila, Oriol, et al.
Publicado: (2022)

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2020)

From systems biology to P4 medicine: applications in respiratory medicine
por: Noell, Guillaume, et al.
Publicado: (2018)

Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge
por: Sibila, Oriol, et al.
Publicado: (2021)

Low birth weight as a potential risk factor for severe COVID-19 in adults
por: Crispi, Fàtima, et al.
Publicado: (2021)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect
por: Faner, Rosa, et al.
Publicado: (2014)

COVID-19 and lung involvement
por: You, Jin-Seok, et al.
Publicado: (2022)

Reply to Guo et al.
por: Wang, Gang, et al.
Publicado: (2023)

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients
por: Millares, Laura, et al.
Publicado: (2019)

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022
por: Halpin, David M. G., et al.
Publicado: (2022)

An investigation of the resolution of inflammation (catabasis) in COPD
por: Noguera, Aina, et al.
Publicado: (2012)

Cellular Senescence in Lung Fibrosis
por: Hernandez-Gonzalez, Fernanda, et al.
Publicado: (2021)

Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity
por: Perea, Lídia, et al.
Publicado: (2020)

Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study
por: Mendoza, Nuria, et al.
Publicado: (2021)

Validity of prognostic models of critical COVID-19 is variable. A systematic review with external validation
por: Cárdenas-Fuentes, Gabriela, et al.
Publicado: (2023)

Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD)
por: Cruz, Tamara, et al.
Publicado: (2019)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

SARS-CoV-2–induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas-Exchange Abnormalities
por: Barbeta, Enric, et al.
Publicado: (2020)

Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD
por: López-Giraldo, Alejandra, et al.
Publicado: (2018)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis
por: Faner, Rosa, et al.
Publicado: (2019)

Estudio histológico mediante biopsia pulmonar post mortem en pacientes con neumonía por COVID-19
por: Sellarés, Jacobo, et al.
Publicado: (2022)

[Translated article] Histology Study of Postmortem Lung Biopsies in Patients With Covid-19 Pneumonia
por: Sellarés, Jacobo, et al.
Publicado: (2022)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations
por: Shafiek, Hanaa, et al.
Publicado: (2015)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

Network medicine analysis of COPD multimorbidities
por: Grosdidier, Solène, et al.
Publicado: (2014)

Treatable traits in the NOVELTY study
por: Agustí, Alvar, et al.
Publicado: (2022)

SARS-CoV-2 and Other Respiratory Viruses: What Does Oxidative Stress Have to Do with It?
por: Fernandes, Iara Grigoletto, et al.
Publicado: (2020)

Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome
por: Chiscano-Camón, Luis, et al.
Publicado: (2020)

Do Temperature and Humidity Affect the Transmission of SARS-CoV-2?-A Flexible Regression Analysis
por: Karim, Md. Rezaul, et al.
Publicado: (2021)

The EASI model: A first integrative computational approximation to the natural history of COPD
por: Agustí, Alvar, et al.
Publicado: (2017)

Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?
por: Al-Tawfiq, Jaffar A.
Publicado: (2020)

Respiratory Coinfections in Children With SARS-CoV-2
por: Westbrook, Adrianna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fedttg8mu3p63p7heahtlm8ti0